Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00476827
Status:
TERMINATED
Last Update Posted:
2013-07-17
First Post:
2007-05-18
Brief Title:
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Sponsor:
Organization:
Duke University